RS Research
Pharmaceutical company developing next generation of nanomedicines based on an innovative drug delivery platform.
Istanbul, Türkiyewww.rsresearch.net ↗
Total raised
€12M
€11,757,563
Funding rounds
2
Investors
5
distinct backers
Active since
2017-04
latest 2021-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood36
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 9y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-15 | Series A | €11M | Eczacıbaşı Momentum,GEN İlaç,GEN Pharmaceuticals,OneLife Ventures | View deal → |
| 2017-04-24 | Other | €1.1M | ACT Venture Capital | View deal → |
Related news
- RS Research, GEN İlaç liderliğinde 12 milyon dolar yatırım aldıwebrazzi.com · 2021-12
- finsmes.com
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Trendyol€1.6BTürkiye · E-commerce
- Getir€1.4BTürkiye · E-commerce
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech